retatrutide sleep Is Too Strong? What to Know About This Powerful New Drug Eli Lilly says next-gen obesity
Description
One is retatrutide, an injectable drug Eli Lilly is developing thats a triple agonist, meaning that in addition to GLP-1 and GIP, it also targets glucagon
W.HoskenI
Still relatively new
Ohrstrom CC, Worm D, Kielgast UL, Holst JJ, Hansen DL (2020) Evidence for relationship between early dumping and postprandial hypoglycemia after Roux-en-Y gastric bypass
Thats why employers also need to support employees with lifestyle changes like diet and exercise alongside meds
GLP-1 , or glucagon-like peptide-1, is a hormone your body naturally produces after eating
